Lantern Pharma (LTRN) 2025 Investment Outlook and Updates
Investing in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
Index values follow a defined daily schedule so investors know when to expect updates. This brief explains the publication times and how to use the data in your investing routine.
21,512 articlesInvesting in early-stage biotech requires a steady playbook. This article breaks down Lantern Pharma (LTRN) in 2025, ...
In a choppy 2026 market, Cathie Wood isn’t chasing high-flying tech alone. She’s quietly adding to positions in three...
For the 16th straight week, home listing prices fall across many markets as higher borrowing costs and rising invento...
Warren Buffett’s moves hint at a bold AI bet. This guide breaks down what makes a killer AI stock and how everyday in...
Insider moves always spark questions. This article unpacks EverCommerce's sells 19,200 shares, what it signals, and h...
Berkshire Hathaway disclosed a new stake in Macy’s in its Q1 2026 13F, a small starter position that contrasts with p...
When a Lincoln Educational director sold a sizable block of shares, investors took note. This article breaks down the...
As Berkshire's new leader, Greg Abel faces a massive cash pile. This article examines why Alphabet is the target, wha...
Coca-Cola has staged a remarkable rally this year, outpacing the broader market. Yet many investors wonder if this ri...
ValueAct Holdings’ move to reduce its stake in Insight Enterprises signals a shifting landscape for enterprise IT spe...
Ethereum reveals a bold 2029 plan to push the base layer toward 10,000 transactions per second and seconds-level fina...
When the holiday season closed, Ross Stores delivered a clear message: steady demand for its off-price model and a ca...